Asset Details
Do you wish to reserve the book?
Statins' protective effects on focal epilepsy are independent of LDL‐C
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Statins' protective effects on focal epilepsy are independent of LDL‐C
Do you wish to request the book?
Statins' protective effects on focal epilepsy are independent of LDL‐C
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Statins' protective effects on focal epilepsy are independent of LDL‐C
2025
Overview
Objective This study evaluates the potential protective effects of statins against epilepsy, focusing on their differential impacts on focal and generalized epilepsy. It investigates the role of statins through the HMGCR gene and associated low‐density lipoprotein (LDL) cholesterol levels. Methods A two‐sample Mendelian randomization (MR) and summary‐data‐based MR (SMR) approach were employed using genetic instruments from genome‐wide association studies (GWASs) and expression quantitative trait loci (eQTLs). Subgroup analyses examined focal and generalized epilepsy, with sensitivity tests, including MR‐Egger regression and MR‐PRESSO, to assess horizontal pleiotropy and robustness. Results SMR analysis found no significant association between HMGCR expression and epilepsy risk across subtypes (p > 0.05). However, inverse‐variance‐weighted MR (IVW‐MR) showed that elevated LDL cholesterol mediated by HMGCR was linked to an increased risk of focal epilepsy (OR = 1.251, 95% CI = 1.135–1.378). No such association was observed for generalized epilepsy. Statins showed promise in reducing post‐stroke epilepsy risk, likely through anti‐inflammatory and neuroprotective effects. Significance The findings suggest that statins' protective effects may be subtype‐specific, particularly in post‐stroke focal epilepsy. Further research is needed to elucidate underlying mechanisms and optimize their therapeutic potential in epilepsy management. Plain Language Summary Statins, drugs typically used to manage cholesterol, may also lower the risk of developing certain types of epilepsy, especially post‐stroke focal epilepsy, by reducing inflammation and protecting brain cells. The research found no clear effect of statins on generalized epilepsy or epilepsy caused by other factors. These results could aid in creating better treatments for epilepsy in the future.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
Subject
/ Disease
/ Epilepsies, Partial - drug therapy
/ Epilepsies, Partial - genetics
/ Epilepsies, Partial - prevention & control
/ Epilepsy
/ Epilepsy, Generalized - blood
/ Epilepsy, Generalized - genetics
/ Epilepsy, Generalized - prevention & control
/ Genome-Wide Association Study
/ Genomes
/ Humans
/ Hydroxymethylglutaryl CoA Reductases - genetics
/ Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology
/ Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
/ Lipids
/ Mendelian Randomization Analysis
/ Original
/ Statins
/ Stroke
